NCT00003534 2018-01-31Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate CancerBurzynski Research InstitutePhase 2 Withdrawn
NCT00003517 2013-07-10Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate CancerNational Cancer Institute (NCI)Phase 2 Withdrawn